These effects, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two support the concept of concentrating on ACKR3 as a singular strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated disorders. In reaction to this https://heleni036kha4.blogpixi.com/profile